## Background: The existence of an effective antitumour immune response in mycosis fungoides (mf) has been shown by the isolation of tumour-specific t-cell clones from such patients. dendritic cells (dcs) are considered crucial for the induction of immunity, including resistance to tumours. apoptot
T and B cells and cell-mediated immunity in mycosis fungoides
✍ Scribed by Barbro C. Nordqvist; John P. Kinney
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 395 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
T anb B cells in peripheral blood were evaluated in 13 patients with mycosis fungoides (MF) and in two patients with Sézary's syndrome. T cells were identified by their capacity to bind sheep red blood cells to their surfaces and the B cells were identified by the presence of surface immunoglobulins in immunofluorescence assay. Seven patients with MF and two with Sézary's syndrome were shown to have T-cell values below normal and elevated levels of null cells, i.e., cells with markers for neither T nor B cells. Low T-cell values and elevated Null-cell values were found predominantly in patients with advanced mycosis fungoides (stages III-IV). Furthermore, these patients had impaired cell-mediated immunity, as shown by in vivo skin testing with recall antigens and attempts at sensitization to dinitrochlorobenzene.
📜 SIMILAR VOLUMES
Composite lymphomas involving cutaneous B-cell and T-cell lymphomas are very uncommon. We report here the unique circumstance of a patient with mycosis fungoides (primary cutaneous T-cell lymphoma) who later developed chronic lymphocytic leukaemia (B-cell lymphoproliferation, B-CLL), which presented
## Abstract Interleukin‐17 (IL‐17) is a proinflammatory cytokine mainly produced by activated CD4^+^ CD45RO T cells. In mice, we have demonstrated that, depending on the model, IL‐17 may act as a tumor growth‐promoting or ‐inhibiting factor. In order to address the relevance of these models in huma